1. Home
  2. JAZZ vs CPB Comparison

JAZZ vs CPB Comparison

Compare JAZZ & CPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$169.80

Market Cap

10.8B

Sector

Health Care

ML Signal

HOLD

Logo Campbell Soup Company

CPB

Campbell Soup Company

HOLD

Current Price

$28.63

Market Cap

9.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAZZ
CPB
Founded
2003
1869
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
10.8B
9.4B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
JAZZ
CPB
Price
$169.80
$28.63
Analyst Decision
Strong Buy
Hold
Analyst Count
15
16
Target Price
$199.20
$32.38
AVG Volume (30 Days)
1.1M
7.9M
Earning Date
11-05-2025
12-09-2025
Dividend Yield
N/A
5.46%
EPS Growth
N/A
5.83
EPS
N/A
1.94
Revenue
$4,157,832,999.00
$10,158,000,000.00
Revenue This Year
$6.00
N/A
Revenue Next Year
$6.84
$1.11
P/E Ratio
N/A
$14.74
Revenue Growth
4.14
2.71
52 Week Low
$95.49
$27.85
52 Week High
$182.99
$43.85

Technical Indicators

Market Signals
Indicator
JAZZ
CPB
Relative Strength Index (RSI) 58.58 39.04
Support Level $164.39 $28.21
Resistance Level $172.00 $29.06
Average True Range (ATR) 4.28 0.75
MACD -1.26 -0.02
Stochastic Oscillator 78.09 25.00

Price Performance

Historical Comparison
JAZZ
CPB

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About CPB Campbell Soup Company

Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2025 (July year-end), snacks accounted for 43% of its revenue, followed by soup (27%), other simple meals (23%), and beverages (7%). Outside its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and recently acquired Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.

Share on Social Networks: